Diageo to Pay A$89 Million to Australian Thalidomide Victims

Diageo Plc agreed to pay A$89 million ($81 million) to settle claims from more than 100 victims of a drug that can cause birth defects, a law firm said.

The settlement with victims of thalidomide was disclosed at a hearing today in the Supreme Court of Victoria in Melbourne, Slater & Gordon, a class-action law firm, said in an e-mailed statement. The individual amounts paid won’t be disclosed, the firm said.